Accelerating the response to TB: Where we are and where we’re going – In this article published ahead of World Tuberculosis Day on March 24, Stacie Stender, an infectious disease expert with Jhpiego, calls for an accelerated global response to TB, which continues to kill over a million people each year, despite being “a disease […]
The Centers for Disease Control and Prevention is recognizing next week’s World TB Day with a report documenting continued progress against tuberculosis at in the United States, along with an troubling trend. The progress: the 3.0 cases per 100,000 people reported in 2013 (9,588 new cases) represents a more than 4 percent drop from 2012. […]
Along with three new grants targeting neglected diseases carried by “kissing bugs” “snail carrying worms” and “gender-bending bacteria,” a second round of grants from the private-public partnership of the Global Health Innovative Technology Fund will continue to target a familiar foe, with an added $5.65 million to develop a vaccine against tuberculosis, The GHIT fund […]
HIV
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]